VISTELLA (Aspen Pharmacare Australia Pty Ltd)
Product name
VISTELLA
Date registered
Evaluation commenced
Decision date
Approval time
154 (255 working days)
Active ingredients
calcifediol monohydrate
Registration type
NCE/ NBE
Indication
Treatment of vitamin D deficiency in adults, and maintenance treatment as required.